Drug Type Small molecule drug |
Synonyms Compound 31 |
Target |
Mechanism ENPP1 inhibitors(Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 inhibitors), STING1 stimulants(Stimulator of interferon genes stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC14H17N4O4P |
InChIKeySQGOUGLKAOTADC-UIKWRGBMSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Triple Negative Breast Cancer | Preclinical | CN | 22 Feb 2024 |